Cognition Therapeutics announced in a peer-reviewed manuscript in the Journal of Neuroscience Research that Cognition scientists identify the sigma-2 receptor as integral in the pathology of Parkinson’s disease. See publication here: https://onlinelibrary.wiley.com/doi/10.1002/jnr.24782